Cargando…
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States
BACKGROUND: Median age at diagnosis of patients with chronic lymphocytic leukemia (CLL) is > 70 years. However, the majority of clinical trials do not reflect the demographics of CLL patients treated in the community. We examined treatment patterns, outcomes, and disease-related mortality in pati...
Autores principales: | Nabhan, Chadi, Mato, Anthony, Flowers, Christopher R., Grinblatt, David L., Lamanna, Nicole, Weiss, Mark A., Davids, Matthew S., Swern, Arlene S., Bhushan, Shriya, Sullivan, Kristen, Flick, E. Dawn, Kiselev, Pavel, Sharman, Jeff P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356242/ https://www.ncbi.nlm.nih.gov/pubmed/28302090 http://dx.doi.org/10.1186/s12885-017-3176-x |
Ejemplares similares
-
Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect(®) CLL Registry
por: Sharman, Jeff P., et al.
Publicado: (2020) -
Real‐world clinical experience in the Connect(®) chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres
por: Mato, Anthony, et al.
Publicado: (2016) -
The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia
por: Nabhan, Chadi, et al.
Publicado: (2011) -
Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States
por: Ma, Xiaomei, et al.
Publicado: (2018) -
“606;” Its Administration 455 Times
por: Ballenger, Edgar G., et al.
Publicado: (1911)